KAYO MOTOR
834058
Zhejiang Zoenn Design
300901
Zhejiang Meorient Commerce & Exhibition Inc.
300795
Fujian Zitian Media Technology
300280
Zhejiang Prulde Electric Appliance
301353
CN Stock MarketDetailed Quotes
600750 Jiangzhong Pharmaceutical
- 21.02
- -0.36-1.68%
Market Closed Dec 13 15:00 CST
13.22BMarket Cap17.62P/E (TTM)
21.40High20.98Low80.52KlotVolume21.31Open21.38Pre Close170.53MTurnover1.28%Turnover Ratio18.67P/E (Static)629.13MShares27.3852wk High3.56P/B13.18BFloat Cap17.6752wk Low23.52Limit Up627.15MShs Float27.38Historical High19.24Limit Down1.96%Amplitude-5.44Historical Low1.80Dividend TTM21.18Avg Price34.73KlotAsk8.56%Div YieldTTM100Lot Size43.56KlotBid
Jiangzhong Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -8.19%2.97B | -8.02%2.17B | -8.74%1.23B | 13.00%4.39B | 12.61%3.24B | 24.26%2.36B | 44.50%1.34B | 35.19%3.89B | 48.33%2.87B | 50.12%1.9B |
| Operating revenue | -8.19%2.97B | -8.02%2.17B | -8.74%1.23B | 13.00%4.39B | 12.61%3.24B | 24.26%2.36B | 44.50%1.34B | 35.19%3.89B | 48.33%2.87B | 50.12%1.9B |
| Other operating revenue | ---- | -19.09%17.62M | ---- | -33.80%26.21M | ---- | -49.24%21.77M | ---- | 121.34%39.58M | ---- | 1,408.43%42.89M |
| Total operating cost | -13.07%2.22B | -13.43%1.6B | -15.24%899.42M | 8.30%3.5B | 10.43%2.55B | 26.36%1.84B | 47.03%1.06B | 38.08%3.23B | 59.61%2.31B | 56.42%1.46B |
| Operating cost | -11.23%960.83M | -13.77%672.58M | -13.08%383.29M | 10.02%1.52B | 12.57%1.08B | 22.83%779.95M | 49.36%440.96M | 35.07%1.38B | 46.96%961.56M | 48.85%634.98M |
| Operating tax surcharges | -2.17%45.31M | 1.66%32.37M | 1.58%17.71M | 4.84%62.65M | 1.15%46.31M | 0.07%31.85M | 15.32%17.43M | 13.93%59.75M | 15.66%45.78M | 21.50%31.82M |
| Operating expense | -15.48%1.06B | -15.17%780.76M | -16.14%451.23M | 7.99%1.63B | 11.07%1.25B | 34.88%920.44M | 52.34%538.07M | 46.17%1.51B | 78.13%1.12B | 71.78%682.39M |
| Administration expense | -5.74%136.35M | -6.80%86.54M | -20.98%39.86M | 2.34%210.62M | 14.50%144.65M | 17.42%92.86M | 32.51%50.45M | 24.70%205.8M | 30.95%126.33M | 19.66%79.08M |
| Financial expense | -37.09%-59.55M | -53.50%-40.82M | -71.23%-21.29M | -116.74%-59.8M | -97.51%-43.44M | -108.35%-26.59M | -57.37%-12.43M | -23.07%-27.59M | 3.43%-21.99M | 19.36%-12.76M |
| -Interest expense (Financial expense) | -93.49%251.88K | -93.24%231.23K | -98.96%16.8K | 59.38%6.98M | 140.90%3.87M | 149.32%3.42M | 2,824.40%1.62M | 26.51%4.38M | 10,874.70%1.61M | 8,188.57%1.37M |
| -Interest Income (Financial expense) | -25.23%-60.13M | -36.59%-41.27M | -51.29%-21.41M | -107.29%-67.64M | -99.13%-48.01M | -110.81%-30.21M | -75.83%-14.15M | -24.08%-32.63M | -4.94%-24.11M | 10.34%-14.33M |
| Research and development | 9.91%77.86M | 42.20%65.05M | 7.41%28.62M | 33.37%133.33M | -2.80%70.84M | 3.88%45.75M | -4.76%26.64M | 13.83%99.97M | 52.60%72.88M | 34.29%44.04M |
| Credit Impairment Loss | 217.78%23.03M | 360.28%23.86M | 658.32%11.4M | 92.70%-1.03M | 10.71%7.25M | 18.73%5.18M | -56.14%1.5M | -74.70%-14.05M | 616.53%6.55M | 648.54%4.37M |
| Asset Impairment Loss | -162,465.75%-8.04M | -153,703.37%-7.61M | ---8.22M | -7,770.23%-8.85M | -99.80%4.95K | -99.88%4.95K | ---- | 91.85%-112.5K | 2,002.27%2.54M | 4,248.57%4.28M |
| Other net revenue | 16.20%50.84M | -6.72%40.14M | -60.14%7.23M | -97.88%1.98M | -41.52%43.76M | -16.19%43.03M | -10.58%18.14M | 2.08%93.11M | 13.93%74.82M | 36.98%51.35M |
| Fair value change income | -85.20%844.29K | -95.09%844.28K | -91.35%620.29K | -164.99%-37.11M | -85.18%5.7M | -23.04%17.21M | -22.10%7.17M | 6.50%57.1M | 25.15%38.49M | 29.49%22.36M |
| Invest income | -373.71%-2.61M | -807.10%-1.44M | 55.27%-156.92K | -167.23%-2.94M | -81.43%953.69K | -103.82%-158.59K | -129.50%-350.86K | 284.88%4.37M | 2,688.24%5.14M | 561.45%4.15M |
| -Including: Investment income associates | -242.61%-1.36M | -198.94%-474.1K | 41.35%-205.78K | -257.74%-2.94M | 72.57%953.69K | -134.83%-158.59K | -129.23%-350.86K | 72.82%-821.16K | 216.85%552.65K | 148.86%455.35K |
| Asset deal income | -5,557.23%-292.78K | 1,334.57%70.26K | 7,296.53%43.74K | 1,008.80%1.22M | -89.21%5.36K | -90.67%4.9K | 117.77%591.41 | -114.87%-134.14K | -94.50%49.7K | -94.20%52.5K |
| Other revenue | 27.04%37.91M | 17.41%24.41M | -63.92%3.54M | 10.34%50.68M | 35.21%29.84M | 28.87%20.79M | 258.01%9.82M | -5.25%45.93M | -33.22%22.07M | -18.25%16.13M |
| Operating profit | 10.30%806.85M | 9.88%616.18M | 11.03%335.22M | 19.47%894.12M | 14.17%731.52M | 13.82%560.78M | 31.66%301.91M | 19.56%748.41M | 14.99%640.71M | 32.93%492.68M |
| Add:Non operating Income | -23.73%6.03M | -10.96%4.82M | -76.30%1.2M | 23.93%9.07M | 226.25%7.91M | 306.72%5.42M | 645.58%5.05M | 237.74%7.32M | 65.20%2.42M | 46.92%1.33M |
| Less:Non operating expense | 291.82%5.32M | 29.05%1.16M | -28.85%356.7K | 147.59%6.05M | 29.68%1.36M | 19.53%902.48K | 289.21%501.3K | -51.25%2.44M | -56.43%1.05M | 215.18%755.02K |
| Total profit | 9.42%807.56M | 9.65%619.84M | 9.66%336.06M | 19.10%897.13M | 14.95%738.07M | 14.61%565.3M | 33.32%306.46M | 20.88%753.28M | 15.43%642.08M | 32.85%493.25M |
| Less:Income tax cost | 11.87%123.67M | 7.99%95.42M | 10.25%51.51M | 22.06%130.47M | 6.60%110.55M | 9.92%88.36M | 28.83%46.72M | 15.94%106.89M | 15.44%103.7M | 46.01%80.39M |
| Net profit | 8.98%683.89M | 9.96%524.42M | 9.55%284.55M | 18.61%766.66M | 16.56%627.52M | 15.52%476.93M | 34.17%259.74M | 21.74%646.39M | 15.42%538.38M | 30.56%412.86M |
| Net profit from continuing operation | 8.98%683.89M | 9.96%524.42M | 9.55%284.55M | 18.61%766.66M | 16.56%627.52M | 15.52%476.93M | 34.17%259.74M | 21.74%646.39M | 15.42%538.38M | 30.56%412.86M |
| Less:Minority Profit | 40.80%49.55M | 31.44%35.67M | 3.38%17.77M | 21.22%58.37M | 5.23%35.19M | 31.92%27.13M | 73.60%17.18M | 90.61%48.15M | 128.98%33.44M | 112.98%20.57M |
| Net profit of parent company owners | 7.09%634.34M | 8.66%488.75M | 9.99%266.78M | 18.40%708.29M | 17.31%592.33M | 14.66%449.8M | 32.04%242.56M | 18.30%598.24M | 11.75%504.94M | 27.96%392.29M |
| Earning per share | ||||||||||
| Basic earning per share | 7.45%1.01 | 8.33%0.78 | 10.26%0.43 | 17.89%1.12 | 17.50%0.94 | 16.13%0.72 | 34.48%0.39 | 18.75%0.95 | 11.11%0.8 | 26.53%0.62 |
| Diluted earning per share | 7.45%1.01 | 8.33%0.78 | 10.26%0.43 | 17.89%1.12 | 17.50%0.94 | 16.13%0.72 | 34.48%0.39 | 18.75%0.95 | 11.11%0.8 | 26.53%0.62 |
| Other composite income | ||||||||||
| Total composite income | 8.98%683.89M | 9.96%524.42M | 9.55%284.55M | 18.61%766.66M | 16.56%627.52M | 15.52%476.93M | 34.17%259.74M | 21.74%646.39M | 15.42%538.38M | 30.56%412.86M |
| Total composite income of parent company owners | 7.09%634.34M | 8.66%488.75M | 9.99%266.78M | 18.40%708.29M | 17.31%592.33M | 14.66%449.8M | 32.04%242.56M | 18.30%598.24M | 11.75%504.94M | 27.96%392.29M |
| Total composite income of minority owners | 40.80%49.55M | 31.44%35.67M | 3.38%17.77M | 21.22%58.37M | 5.23%35.19M | 31.92%27.13M | 73.60%17.18M | 90.61%48.15M | 128.98%33.44M | 112.98%20.57M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
